Paul Tudor Jones Astrazeneca PLC Put Options Transaction History

Tudor Investment Corp Et Al

  • $25.1 Billion
  • Q4 2024

Put Options

3 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2024

Feb 14, 2025
BUY
$63.2 - $79.58 $524,560 - $660,514
8,300 Added 188.64%
12,700 $832,000
Q3 2024

Nov 14, 2024
BUY
$76.67 - $87.62 $337,348 - $385,528
4,400 New
4,400 $342,000
Q4 2023

Feb 14, 2024
BUY
$61.89 - $69.28 $1.83 Million - $2.04 Million
29,500 New
29,500 $1.99 Million

Others Institutions Holding AZN

# of Institutions
1,353
Shares Held
512M
Call Options Held
6.08M
Put Options Held
4.44M
View Full List

About ASTRAZENECA PLC

AZN Quotes by TradingView
  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $232B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track Paul Tudor Jones's Portfolio

Track Paul Tudor Jones Portfolio

Follow Paul Tudor Jones (Tudor Investment Corp Et Al) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email